Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 3
1957 3
1960 3
1963 4
1964 51
1965 73
1966 99
1967 124
1968 158
1969 131
1970 141
1971 195
1972 239
1973 280
1974 371
1975 489
1976 593
1977 583
1978 725
1979 757
1980 1015
1981 990
1982 1017
1983 1164
1984 1193
1985 1323
1986 1332
1987 1305
1988 1248
1989 1482
1990 1438
1991 1420
1992 1371
1993 1371
1994 1303
1995 1239
1996 1167
1997 1147
1998 1056
1999 1049
2000 983
2001 960
2002 936
2003 913
2004 887
2005 908
2006 931
2007 960
2008 894
2009 852
2010 847
2011 824
2012 850
2013 770
2014 773
2015 777
2016 713
2017 718
2018 671
2019 695
2020 732
2021 658
2022 572
2023 563
2024 262

Text availability

Article attribute

Article type

Publication date

Search Results

47,209 results

Results by year

Filters applied: . Clear all
Page 1
Rectal indometacin to prevent pancreatitis after extracorporeal shock wave lithotripsy (RIPEP): a single-centre, double-blind, randomised, placebo-controlled trial.
Qian YY, Ru N, Chen H, Zou WB, Wu H, Pan J, Li B, Xin L, Guo JY, Tang XY, Hu LH, Jin ZD, Wang D, Du YQ, Wang LW, Li ZS, Liao Z. Qian YY, et al. Lancet Gastroenterol Hepatol. 2022 Mar;7(3):238-244. doi: 10.1016/S2468-1253(21)00434-9. Epub 2022 Jan 25. Lancet Gastroenterol Hepatol. 2022. PMID: 35085482 Clinical Trial.
Post-ESWL pancreatitis occurred in 60 (9%) patients in the rectal indometacin group and 84 (12%) patients in the placebo group (relative risk 0.71, 95% CI 0.52-0.98; p=0.042). Transient adverse events occurred in 235 (34%) patients in the rectal indometacin group an …
Post-ESWL pancreatitis occurred in 60 (9%) patients in the rectal indometacin group and 84 (12%) patients in the placebo group (relat …
Single dose oral indometacin for the treatment of acute postoperative pain.
Mason L, Edwards J, Moore RA, McQuay HJ. Mason L, et al. Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD004308. doi: 10.1002/14651858.CD004308.pub2. Cochrane Database Syst Rev. 2004. PMID: 15495100 Free PMC article. Review.
When taken for chronic pain conditions, indometacin has been associated with a high incidence of adverse events. ...REVIEWERS' CONCLUSIONS: Conclusions about the clinical efficacy of indometacin for postoperative cannot be made until more trials are conducted for a …
When taken for chronic pain conditions, indometacin has been associated with a high incidence of adverse events. ...REVIEWERS' CONCLU …
Solubilization of indometacin.
El-Sabbagh H, Ghanem AH, Abdel-Alim HM. El-Sabbagh H, et al. Pharmazie. 1978 Aug;33(8):529-31. Pharmazie. 1978. PMID: 724785
Three methods were employed for the solubilization of indometacin as an example of antirheumatic drugs, employing:--Non-ionic surface-active agents such as Tween 80 and 40, Myrj 53 and Brij 99,--urea and sodium citrate--urea-indometacin coprecipitate. ...Urea-ind …
Three methods were employed for the solubilization of indometacin as an example of antirheumatic drugs, employing:--Non-ionic surface …
The use of quantum chemistry in pharmaceutical research as illustrated by case studies of indometacin and carbamazepine.
Gordon KC, McGoverin CM, Strachan CJ, Rades T. Gordon KC, et al. J Pharm Pharmacol. 2007 Feb;59(2):271-7. doi: 10.1211/jpp.59.2.0013. J Pharm Pharmacol. 2007. PMID: 17270080 Review.
A brief introduction to quantum methods is provided and the use of these methods in understanding the structure and properties of indometacin and carbamazepine is discussed. The use of calculated structures and molecular electrostatic potentials in developing quantitative …
A brief introduction to quantum methods is provided and the use of these methods in understanding the structure and properties of indomet …
Atropisomerism observed in indometacin derivatives.
Takahashi H, Wakamatsu S, Tabata H, Oshitari T, Harada A, Inoue K, Natsugari H. Takahashi H, et al. Org Lett. 2011 Feb 18;13(4):760-3. doi: 10.1021/ol103008d. Epub 2011 Jan 20. Org Lett. 2011. PMID: 21250752
To elucidate the active conformation of indometacin that differentiates between cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), the stereochemistry around the N-benzoylated indole moiety of indometacin was studied. ...
To elucidate the active conformation of indometacin that differentiates between cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) …
[Indomethacin].
Granerud ES, Munthe E. Granerud ES, et al. Tidsskr Nor Laegeforen. 1977 Apr 30;97(12):578-9. Tidsskr Nor Laegeforen. 1977. PMID: 300908 Norwegian. No abstract available.
Effectiveness of indometacin to prevent ovulation in modified natural-cycle IVF: a randomized controlled trial.
Rijken-Zijlstra TM, Haadsma ML, Hammer C, Burgerhof JG, Pelinck MJ, Simons AH, van Echten-Arends J, Arts JG, Land JA, Groen H, Hoek A. Rijken-Zijlstra TM, et al. Reprod Biomed Online. 2013 Sep;27(3):297-304. doi: 10.1016/j.rbmo.2013.05.009. Epub 2013 May 22. Reprod Biomed Online. 2013. PMID: 23876971 Clinical Trial.
Therefore, addition of indometacin may improve the effectiveness of modified natural-cycle IVF. ...Although this study could not detect a significantly lower ovulation rate in the indometacin group versus the placebo group, the data suggest that a subgroup of patien …
Therefore, addition of indometacin may improve the effectiveness of modified natural-cycle IVF. ...Although this study could not dete …
Indometacin as prophylaxis for heterotopic ossification after the operative treatment of fractures of the acetabulum.
Karunakar MA, Sen A, Bosse MJ, Sims SH, Goulet JA, Kellam JF. Karunakar MA, et al. J Bone Joint Surg Br. 2006 Dec;88(12):1613-7. doi: 10.1302/0301-620X.88B12.18151. J Bone Joint Surg Br. 2006. PMID: 17159174 Free article. Clinical Trial.
Our study was designed to compare the effect of indometacin with that of a placebo in reducing the incidence of heterotopic ossification in a prospective, randomised trial. ...Significant ossification of Brooker grade III to IV occurred in nine of 59 patients (15.2%) in th …
Our study was designed to compare the effect of indometacin with that of a placebo in reducing the incidence of heterotopic ossificat …
A novel synthetic carbon and oxygen doped stalactite-like g-C(3)N(4) for broad-spectrum-driven indometacin degradation.
Zheng X, Zhang Q, Chen T, Wu Y, Hao J, Tan C, Chen P, Wang F, Liu H, Lv W, Liu G. Zheng X, et al. J Hazard Mater. 2020 Mar 15;386:121961. doi: 10.1016/j.jhazmat.2019.121961. Epub 2019 Dec 26. J Hazard Mater. 2020. PMID: 31901544
The 0.3COCN demonstrated an excellent photocatalytic degradation of indometacin (IDM), which was 5.9 times higher than bulk g-C(3)N(4). ...
The 0.3COCN demonstrated an excellent photocatalytic degradation of indometacin (IDM), which was 5.9 times higher than bulk g-C(3)N(4 …
Indometacin: renal handling and effects in the isolated perfused rat kidney.
Cox PG, Moons MM, Russel FG, van Ginneken CA. Cox PG, et al. Pharmacology. 1991;42(5):287-96. doi: 10.1159/000138810. Pharmacology. 1991. PMID: 1876609
We investigated renal handling and effects of indometacin on renal function in the isolated perfused rat kidney (IPK). Indometacin concentrations less than 2.5 ng/ml did not influence renal function, while higher concentrations caused a decrease in urinary flow and …
We investigated renal handling and effects of indometacin on renal function in the isolated perfused rat kidney (IPK). Indometacin …
47,209 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "indometacin"